Renascent Pharma Private Limited - Company Profile

It is a business services private limited company based in Palam Vihar, Haryana, India, established in 2023.
2023 Palam Vihar, Haryana, India Active
Last Updated:
Access Report
About Renascent Pharma Private Limited

Renascent Pharma Private Limited, a active private limited company, was established on 14 March 2023 in Palam Vihar, Haryana, India. it holds CIN: U46901HR2023PTC109901. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.

Its leadership includes Tapash Barooah (Director), Suresh Singh Kr (Director). Past directors included Maheshwar Singh Pangtey. Its latest AGM occurred on 20 December 2024, with the balance sheet filed on 31 March 2024. It is based at 136,Ground Floor, Near Water Tank,, Sector 23,Catarpuri Alias,Daulatpur Nasirabad, Palam Vihar, Haryana, 122017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46901HR2023PTC109901

  • Registration Number

    109901

  • Incorporation Date

    14 March 2023

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 2 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Renascent Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Renascent Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Renascent Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Tapash Barooah Director 14 Mar 2023 Current
Suresh Singh Kr Director 14 Mar 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Renascent Pharma.

Enhance accessibility to Renascent Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Renascent Pharma revenue growth over time
Renascent Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Renascent Pharma?

Unlock access to Renascent Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Renascent Pharma?

Unlock and access historical data on people associated with Renascent Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Renascent Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renascent Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Renascent Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Renascent Pharma Private Limited last Annual general meeting of members was held on 20 Dec 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Renascent Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Tapash Barooah was appointed as a Director was appointed as a Director on 14 Mar 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Director Appointment

    Suresh Singh Kr was appointed as a Director was appointed as a Director on 14 Mar 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Company Incorporation

    The activity Renascent Pharma Private Limited was registered on 14 Mar 2023 with Roc Delhi & aged 2 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Renascent Pharma Private Limited?

The CIN of Renascent Pharma Private Limited is U46901HR2023PTC109901.

Where is Renascent Pharma Private Limited headquartered?

Renascent Pharma Private Limited is headquartered at 136,Ground Floor, Near Water Tank,, Sector 23,Catarpuri Alias,Daulatpur Nasirabad, Palam Vihar, Haryana, 122017.

When was Renascent Pharma Private Limited incorporated?

Renascent Pharma Private Limited was incorporated on 14 March 2023.

Who are the current directors of Renascent Pharma Private Limited?

The current directors of Renascent Pharma Private Limited are

Is Renascent Pharma Private Limited a listed company?

Renascent Pharma Private Limited is unlisted.

What is the capital structure of Renascent Pharma Private Limited?

The authorized capital of Renascent Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available